Dr. Md Ibrahim is an Assistant Professor of Pharmacology, Cancer Biology, and Pharmaceutical Science at California Northstate University College of Pharmacy and founder of Oncovask Therapeutics LLC. His research focuses on overcoming cancer therapy resistance by targeting DNA damage repair pathways and replication stress responses.
He develops RNA-based therapeutics, including siRNA-loaded lipid nanoparticles, to silence undruggable DNA repair and checkpoint factors in glioblastoma, ovarian, and breast cancers. His work integrates proximity labeling (Split-TurboID), proteomics, and mechanistic studies of base excision repair and replication stress to restore sensitivity to PARP inhibitors, temozolomide, and alkylating agents.
Dr. Ibrahim also leads precision medicine efforts to repurpose FDA-approved drugs for rare cancers, investigates dormancy and metastasis in breast cancer using microfluidic tumor-on-chip models, and studies DNA repair dysfunction in neurodegenerative diseases such as ALS. His laboratory develops microfluidic and immunofluorescence-based diagnostic platforms for circulating tumor cell detection and precision monitoring.
In collaboration with experts in data science and materials science, he is building predictive oncology models that integrate omics and clinical datasets to personalize cancer treatment.
Education
2022
Ph.D. in Biomedical Sciences (Cancer Biology)
University of South Alabama, Whiddon College of Medicine, Department of Pharmacology, Mitchell Cancer Institute, Molecular and Metabolic Oncology Program
2013
Masters of Pharmaceutical Science
Bangladesh
2011
Bachelor of Pharmaceutical Science
Bangladesh
Discoveries in Cancer, DNA Repair, and Therapeutics
2025
2024
2021
2015 - 2020
TRIP12's role in the governance of DNA polymerase β involvement in DNA damage response and repair
Authors: Inanc, B., Fang, Q., Roos, W. P., Andrews, J. F., Zeng, X., Clark, J., Li, J., Dey, N. B., Ibrahim, M., Sykora, P., Yu, Z., Pearson, C. R., Braganza, A., Verheij, M., Jonkers, J., Yates, N. A., Vens, C., & Sobol, R. W.
TRIP12 governs DNA Polymerase β involvement in DNA damage response and repair
Authors: Inanc, B., Fang, Q., Andrews, J. F., Zeng, X., Clark, J., Li, J., Dey, N. B., Ibrahim, M., Sykora, P., Yu, Z., Braganza, A., Verheij, M., Jonkers, J., Yates, N. A., Vens, C., & Sobol, R. W.
A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells
Authors: Li, J., Garavaglia, S., Ye, Z., Moretti, A., Belyaeva, O. V., Beiser, A., Ibrahim, M., Wilk, A., McClellan, S., Klyuyeva, A. V., Goggans, K. R., Kedishvili, N. Y., Salter, E. A., Wierzbicki, A., Migaud, M. E., Mullett, S. J., Yates, N. A., Camacho, C. J., Rizzi, M., & Sobol, R. W.
NAD+ bioavailability mediates PARG inhibition-induced replication arrest, intra S-phase checkpoint and apoptosis in glioma stem cells
Authors: Li, J., M Saville, K., Ibrahim, M., Zeng, X., McClellan, S., Angajala, A., Beiser, A., Andrews, J. F., Sun, M., Koczor, C. A., Clark, J., Hayat, F., Makarov, M. V., Wilk, A., Yates, N. A., Migaud, M. E., & Sobol, R. W.
Temporal dynamics of base excision/single-strand break repair protein complex assembly/disassembly are modulated by the PARP/NAD+/SIRT6 axis
Authors: Koczor, C. A., Saville, K. M., Andrews, J. F., Clark, J., Fang, Q., Li, J., Al-Rahahleh, R. Q., Ibrahim, M., McClellan, S., Makarov, M. V., Migaud, M. E., & Sobol, R. W.
An in vivo study of the pharmacological activities of a methanolic acetate fraction of Pistia stratiotes L.: An ethno-medicinal plant used in Bangladesh
Authors: Hussain, M. S., Ibrahim, M., Hasan, M. M., Aziz, M. T., Suchi, S. A., & Uddin, M. G.
Therapeutic Potentiality of Diospyros blancoi Linn. Seeds Against Pain, Thrombus and Inflammation: An in vivo and in vitro Study
Authors: Ibrahim, M., Hussain, M. S., Sultana, F., Abhi, N., Ahmed, T., Uddin, S. M. N., Rahaman, A., Azmerin, M., Aka, T. D., Mosharraf, S., & Uddin, A. H. M.